Role of Alfuzosin in Ureteral Stent Related Urinary Symptoms Score: A Comparative Study

Background: Ureteral stent placement is a routine urological procedure. However, patients inserted with ureteral stent exhibited increased urinary symptoms that compromise patients’ quality of life.Objective: To assess the efficacy of alpha blockers (Alfuzosin) in the management of ureteral stent re...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Gandaki Medical College (Print) Vol. 10; no. 1; pp. 28 - 30
Main Authors: Shrestha, Santosh, Adhikari, DB, Gurung, A, Pradhan, S, Gurung, NV, Acharya, A, Shrestha, D, Poudel, SR, Chapagain, A, Lamichhane, P
Format: Journal Article
Language:English
Published: Gandaki Medical College Teaching Hospital & Research Centre Pvt. Ltd 01-08-2017
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Ureteral stent placement is a routine urological procedure. However, patients inserted with ureteral stent exhibited increased urinary symptoms that compromise patients’ quality of life.Objective: To assess the efficacy of alpha blockers (Alfuzosin) in the management of ureteral stent related urinary symptoms.Methods: Total of 60 patients after ureteral stent insertion was randomly divided into two equal groups; 30 in alfuzosin group and the remaining 30 in control group. Urinary symptoms questionnaire was filled after two weeks and results were statistically analyzed.Results: Urinary symptoms like urgency, frequency and flank pain were significantly less in the alfuzosin group when compared with control group.Conclusion: Alpha blocker (Alfuzosin) was found to be effective in reducing ureteral stent related urinary symptoms.Journal of Gandaki Medical CollegeVol. 10, No. 1, 2017, page: 28-30
ISSN:2070-4240
2070-4259
DOI:10.3126/jgmcn.v10i1.17912